Drug Profile
Research programme: drug-eluting resorbable scaffold - Arterial Remodeling Technologies/Terumo
Latest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Arterial Remodeling Technologies; Terumo
- Developer Terumo
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Coronary artery disease
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for preclinical development in Coronary artery disease in France (Intra-articular, Implant)
- 28 Jun 2019 No recent reports of development identified for preclinical development in Coronary artery disease in Japan (Intra-articular, Implant)